Marker Therapeutics, Inc.

Historical 13F Holders

Symbol
MRKR
CUSIP
57055L206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 57055L206 since 12/18/2024, newest first.

Filer % of Class Filed
New Enterprise Associates 16, L.P. 13D/A Amendment 5
9.9% 11/17/2025
Event 11/13/2025
Alyeska Investment Group, L.P. 13G/A Amendment 1
9.9% 11/14/2025
Event 9/30/2025
New Enterprise Associates 16, L.P. 13D/A Amendment 4
12.6% 8/18/2025
Event 8/14/2025
Blue Owl Capital Holdings LP 13G/A Amendment 1 10.0% 5/15/2025
Event 3/31/2025
Alyeska Investment Group, L.P. 13G
10.0% 2/14/2025
Event 12/31/2024
Blue Owl Capital Holdings LP 13G 5.2% 2/14/2025
Event 12/31/2024
New Enterprise Associates 16, L.P. 13D/A Amendment 3
15.2% 12/23/2024
Event 12/19/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 35 3.97 M $5.84 M
2026 Q1 35 3.90 M $5.07 M
2025 Q4 36 4.04 M $6.03 M
2025 Q3 33 3.46 M $3.09 M
2025 Q2 32 3.41 M $5.22 M
2025 Q1 32 4.02 M $4.95 M
2024 Q4 33 4.40 M $49.3 M
2024 Q3 29 1.94 M $5.46 M
2024 Q2 30 1.94 M $10.5 M
2024 Q1 31 1.92 M $8.25 M
2023 Q4 28 1.91 M $10.5 M
2023 Q3 28 1.87 M $8.50 M
2023 Q2 29 1.82 M $5.66 M
2023 Q1 28 1.63 M $1.15 M